ESCRT may function as a tumor biomarker, transitioning from pan-cancer analysis to validation within breast cancer.
Saved in:
| Title: | ESCRT may function as a tumor biomarker, transitioning from pan-cancer analysis to validation within breast cancer. |
|---|---|
| Authors: | Chen XR; Qingdao Medical College, Qingdao University, Qingdao, China.; Clinical Laboratory Department, Qingdao Municipal Hospital, Qingdao, China., Tan XY; Clinical Laboratory Department, Qingdao Municipal Hospital, Qingdao, China., Zhang ZL; Department of Urology, Affiliated Hospital of Qingdao University, Qingdao, China., Yuan JS; Clinical Laboratory Department, Qingdao Municipal Hospital, Qingdao, China., Song WQ; Qingdao Medical College, Qingdao University, Qingdao, China.; Clinical Laboratory Department, Qingdao Municipal Hospital, Qingdao, China. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Mar 31; Vol. 16, pp. 1531940. Date of Electronic Publication: 2025 Mar 31 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2025.1531940 |
